Lanean...
High-throughput flow cytometry (HTFC) drug combination discovery with novel synergy analysis software, SynScreen
Classical therapeutic regimens are subject to toxicity, low efficacy, and/or the development of drug resistance. Thus, the discovery of synergistic drug combinations would permit treatment with lower, tolerable dosages of each agent and restored sensitivity. We describe the development and use of th...
Gorde:
| Argitaratua izan da: | SLAS Discov |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6363001/ https://ncbi.nlm.nih.gov/pubmed/29842834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2472555218775913 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|